Fatty acid synthase regulates the pathogenicity of Th17 cells KE Young, S Flaherty, KM Woodman, N Sharma‐Walia, JM Reynolds Journal of leukocyte biology 102 (5), 1229-1235, 2017 | 70 | 2017 |
T peripheral helper cells in autoimmune diseases KE Marks, DA Rao Immunological Reviews 307 (1), 191-202, 2022 | 58 | 2022 |
Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes F Zhang, AH Jonsson, A Nathan, N Millard, M Curtis, Q Xiao, ... Nature, 1-9, 2023 | 46 | 2023 |
Toll-like Receptor 2 in Autoimmune Inflammation KE Marks, K Cho, C Stickling, JM Reynolds Immune Network 21 (3), 2021 | 28 | 2021 |
Clonally expanded CD38hi cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor–associated arthritis R Wang, A Singaraju, KE Marks, L Shakib, G Dunlap, I Adejoorin, ... Science immunology 8 (85), eadd1591, 2023 | 22 | 2023 |
Toll-like receptor 2 induces pathogenicity in Th17 cells and reveals a role for IPCEF in regulating Th17 cell migration KE Marks, S Flaherty, KM Patterson, M Stratton, GJ Martinez, ... Cell reports 35 (13), 2021 | 14 | 2021 |
Rheumatoid arthritis disease activity assessed by patient-reported outcomes and flow cytometry before and after an additional dose of COVID-19 vaccine SK Tedeschi, J Stratton, JE Ellrodt, MG Whelan, K Hayashi, K Yoshida, ... Annals of the Rheumatic Diseases 81 (7), 1045-1048, 2022 | 13 | 2022 |
Importance of Shared Treatment Goal Discussions in Rheumatoid Arthritis—A Cross‐Sectional Survey: Patients Report Providers Seldom Discuss Treatment Goals and Outcomes Improve … KD O’Neill, KE Marks, PS Sinicrope, CS Crowson, D Symons, ... ACR Open Rheumatology 3 (12), 870-878, 2021 | 5 | 2021 |
Associations between rheumatoid arthritis clinical factors with synovial cell types and states D Weisenfeld, F Zhang, L Donlin, AH Jonsson, W Apruzzese, D Campbell, ... Arthritis & Rheumatology, 2023 | 4 | 2023 |
Humoral and cellular immune responses in persons with rheumatoid arthritis after a third dose of mRNA COVID-19 vaccine SK Tedeschi, DH Solomon, Y Chen, J Ellrodt, MG Whelan, J Stratton, ... Seminars in Arthritis and Rheumatism 59, 152177, 2023 | 4 | 2023 |
High-dimensional immunophenotyping reveals immune cell aberrations in patients with undiagnosed inflammatory and autoimmune diseases AA Mueller, T Sasaki, JW Keegan, JP Nguyen, A Griffith, AM Horisberger, ... The Journal of Clinical Investigation, 2023 | 2 | 2023 |
RA Presents in Disease Patterns Impacting Treatment Response K Marks, D Symons, C Crowson, P Sinicrope, K O'Neill ARTHRITIS & RHEUMATOLOGY 71, 2019 | 2 | 2019 |
Toll-like receptor 2 induces pathogenicity in Th17 cells and reveals a role for interactor protein for cytohesin exchange factors 1 (IPCEF) in regulating Th17 cell migration K Marks, S Flaherty, M Stratton, GJ Martinez, JM Reynolds Available at SSRN 3701221, 2021 | 1 | 2021 |
Relationships Between Disease Patterns in RA and Rheumatology Treatment K O'Neill, K Marks, J Davis, C Crowson ARTHRITIS & RHEUMATOLOGY 72, 2020 | 1 | 2020 |
OP0015 CD38HI CYTOTOXIC CD8 T CELLS ARE EXPANDED FOLLOWING CHECKPOINT BLOCKADE AND CHARACTERIZE THE T CELL INFILTRATE IN CHECKPOINT INHIBITOR-ASSOCIATED ARTHRITIS A Singaraju, KE Marks, R Wang, L Shakib, G Dunlap, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 10-11, 2023 | | 2023 |
Relationship Between Humoral and Cellular Immune Responses in Persons with Rheumatoid Arthritis Following a Third Dose of COVID-19 Vaccine S Tedeschi, D Solomon, Y Chen, J Ellrodt, MG Whelan, J Stratton, ... ARTHRITIS & RHEUMATOLOGY 74, 1568-1570, 2022 | | 2022 |
Themes in Patients' Discordance with Provider's Rheumatoid Arthritis Treatment Goals Relate to Patient Age, Gender, and Ethnicity K O'Neill, P Sinicrope, C Crowson, K Marks, R Giblon, E Myasoedova, ... ARTHRITIS & RHEUMATOLOGY 74, 399-401, 2022 | | 2022 |
Distinct Effects of JAK Inhibitor and TNF Inhibitors on Circulating B Cell Phenotypes in Rheumatoid Arthritis Patients M Elahee, K Marks, I Adejoorin, L Chen, D Todd, J Coblyn, E Massarotti, ... ARTHRITIS & RHEUMATOLOGY 74, 1246-1248, 2022 | | 2022 |
Rheumatoid Arthritis Patient Discordance with Provider Treatment Goals Is Associated with Poorer RA Outcomes K O'Neill, P Sinicrope, C Crowson, K Marks, R Giblon, E Myasoedova, ... ARTHRITIS & RHEUMATOLOGY 74, 4464-4467, 2022 | | 2022 |
POS0402 CLONALLY EXPANDED CD38hi CYTOTOXIC CD8 T CELLS DEFINE THE T CELL INFILTRATE IN CHECKPOINT INHIBITOR-ASSOCIATED ARTHRITIS R Wang, A Singaraju, KE Marks, L Shakib, G Dunlap, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 457-457, 2022 | | 2022 |